Pharma Companies Pressed To Give Up Patents On Potential COVID-19 Treatments; Gates Foundation, Wellcome To Fund Drug Trials; U.S. Signs Deal With Companies To Produce Potential Vaccines

AFP/France 24: NGOs press drug firm Gilead over potential virus treatment (3/30).

Financial Times: Big drugmakers under pressure to share patents against coronavirus (Mancini, 3/31).

Financial Times: Gates Foundation and Wellcome Trust to fund Covid-19 drug trials (Kuchler, 3/30).

Reuters: J&J, Moderna sign deals with U.S. to produce possible coronavirus vaccines (Steenhuysen, 3/30).

Roll Call: Blockchain could transform supply chains, aid in COVID-19 fight (Reilly, 3/31).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.